These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 15273422
1. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake. Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L. Kidney Blood Press Res; 2004; 27(4):203-10. PubMed ID: 15273422 [Abstract] [Full Text] [Related]
2. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats. Vanecková I, Kramer HJ, Novotná J, Kazdová L, Opocenský M, Bader M, Ganten D, Cervenka L. Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515 [Abstract] [Full Text] [Related]
3. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats. Husková Z, Kramer HJ, Vanourková Z, Cervenka L. J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655 [Abstract] [Full Text] [Related]
5. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats. Vanecková I, Skaroupková P, Dvorák P, Certíková Chábová V, Tesar V, Bader M, Ganten D, Kramer HJ. Physiol Res; 2005 Mar; 54(1):17-24. PubMed ID: 15717837 [Abstract] [Full Text] [Related]
6. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats. Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L. Kidney Blood Press Res; 2004 Mar; 27(4):248-58. PubMed ID: 15286437 [Abstract] [Full Text] [Related]
7. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats. Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L. Kidney Blood Press Res; 2007 Mar; 30(1):45-55. PubMed ID: 17259738 [Abstract] [Full Text] [Related]
8. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats. Kopkan L, Kramer HJ, Husková Z, Vanourková Z, Bäcker A, Bader M, Ganten D, Cervenka L. J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925 [Abstract] [Full Text] [Related]
9. The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats. Certíková Chábová V, Kramer HJ, Vanecková I, Thumová M, Skaroupková P, Tesar V, Falck JR, Imig JD, Cervenka L. Kidney Blood Press Res; 2007 Apr; 30(5):335-46. PubMed ID: 17785988 [Abstract] [Full Text] [Related]
10. Role of nNOS in regulation of renal function in hypertensive Ren-2 transgenic rats. Cervenka L, Kramer HJ, Malý J, Vanecková I, Bäcker A, Bokemeyer D, Bader M, Ganten D, Mitchell KD. Physiol Res; 2002 Apr; 51(6):571-80. PubMed ID: 12511180 [Abstract] [Full Text] [Related]
11. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L. Vascul Pharmacol; 2007 Apr; 47(2-3):145-59. PubMed ID: 17604232 [Abstract] [Full Text] [Related]
12. General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system. Castrop H, Klar J, Wagner C, Hocherl K, Kurtz A. Am J Physiol Renal Physiol; 2003 Mar; 284(3):F518-24. PubMed ID: 12441308 [Abstract] [Full Text] [Related]
13. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. Opocenský M, Dvorák P, Malý J, Kramer HJ, Bäcker A, Kopkan L, Vernerová Z, Tesar V, Zima T, Bader M, Ganten D, Janda J, Vanecková I. Physiol Res; 2004 Mar; 53(6):581-93. PubMed ID: 15588125 [Abstract] [Full Text] [Related]
14. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension. Patterson ME, Mullins JJ, Mitchell KD. Am J Physiol Renal Physiol; 2008 Jan; 294(1):F205-11. PubMed ID: 17977909 [Abstract] [Full Text] [Related]
15. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats. Jacinto SM, Mullins JJ, Mitchell KD. Am J Physiol; 1999 Feb; 276(2):F315-22. PubMed ID: 9950963 [Abstract] [Full Text] [Related]
16. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension. Opay AL, Mouton CR, Mullins JJ, Mitchell KD. Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181 [Abstract] [Full Text] [Related]
18. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats. Husková Z, Kramer HJ, Thumová M, Vanourková Z, Bürgelová M, Teplan V, Malý J, Cervenka L. Kidney Blood Press Res; 2006 Aug; 29(2):74-83. PubMed ID: 16651849 [Abstract] [Full Text] [Related]
19. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats. Vernerová Z, Kramer HJ, Bäcker A, Cervenka L, Opocenský M, Husková Z, Vanourková Z, Eis V, Chábová VC, Tesar V, Malý J, Vanecková I. Vascul Pharmacol; 2008 Aug; 48(4-6):165-73. PubMed ID: 18372220 [Abstract] [Full Text] [Related]
20. Ovariectomy enhances renal cortical expression and function of cyclooxygenase-2. Tada Y, Ichihara A, Koura Y, Okada H, Kaneshiro Y, Hayashi M, Saruta T. Kidney Int; 2004 Nov; 66(5):1966-76. PubMed ID: 15496168 [Abstract] [Full Text] [Related] Page: [Next] [New Search]